Germany’s CureVac jab shows only 47% effectiveness
German biotech CureVac NV said on Wednesday that its Covid-19 vaccine was only 47% effective in a late-stage trial, missing the main objective of the study and casting doubt on the possible delivery of hundreds of millions of doses to the Union. European, Reuters reports.
The disappointing efficacy of the injection known as CVnCoV emerged from an interim analysis based on 134 cases of Covid-19 in the study with nearly 40,000 volunteers in Europe and Latin America.
The stakes for CureVac and potential buyers of its vaccine in Europe had risen after age limits were imposed on the use of the Johnson & Johnson and AstraZeneca vaccines due to a link to extremely rare but potentially bleeding disorders. fatal.
The CureVac injection was also expected to help low- and middle-income countries that have lagged far behind the wealthiest nations in the global immunization campaign.
As the only major supply agreements for CureVac, the European Union in November secured up to 405 million doses of the vaccine, of which 180 million are optional. This was followed by a memorandum of understanding with Germany for another 20 million doses.
CureVac’s US-listed shares fell 50.6% to $ 46.81 in after-hours trading after the data was released.
Hello and welcome to today’s live coverage of the coronavirus pandemic.
Japan plans to lift the virus emergency in Tokyo on June 20, a month before the Olympics, the government announced Thursday, as reports said only 10,000 spectators would be allowed at Games events.
Meanwhile, German biotech CureVac NV said on Wednesday that its Covid-19 vaccine showed only 47% efficacy in a late-stage trial, missing the main goal of the study and casting doubt on the possible delivery of hundreds of millions of dose to the European Union.
Here are the key recent developments:
- MPs in England voted 461 to 60 to pass regulations delaying the easing of coronavirus restrictions in England to July 19.
- South Africa’s Covid-19 infections rose by 13,246 on Wednesday, the highest daily total in five months, his government said.
- US President Joe Biden said that China was trying to project itself as a responsible nation regarding the Covid-19 pandemic. But it was not clear whether Beijing was really trying to understand the origins of the coronavirus.
- Johnson & Johnson is expected to miss its target for supplying Covid vaccines to the EU during the second quarter after the use of millions of doses was banned in Europe for safety reasons, according to the European Commission.
- France and Spain moves to ease the rules on wearing face masks in the open air, in a development attributed by both countries to their Covid-19 vaccination campaigns.
- TOStralia’s second-largest city will allow its five million residents to travel more than 15 miles from home. and end the mandatory use of outdoor masks as of Friday.
- Ursula von der Leyen signed the first plans by EU member states to spend the 800 billion euro (£ 687 billion) Covid recovery fund from Brussels. while seeking to reverse the reputational damage inflicted on the bloc by the pandemic during a visit to Portugal and Spain.
- All nursing home staff in England will need to be fully vaccinated against coronavirus under a controversial new law, announced the government.
- Codogno, the town where the first domestic transmission of Covid-19 was detected in Italy, has registered zero infections among its inhabitants for the first time since February 2020.
- From the end of June, companies in Germany will no longer be obliged to allow working from home, Chancellor Angela Merkel’s chief of staff said.
- Taj Mahal reopened to the public as India pushes to lift restrictions in an attempt to revitalize its economy.
George is Digismak’s reported cum editor with 13 years of experience in Journalism